As of March 31, 2026, CUROHOLDINGS Co., Ltd. carries a market capitalization of 17.84B, placing it among publicly traded companies globally. Its enterprise value stands at 58.11B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 17.84B |
| Enterprise Value | 58.11B |
As of March 31, 2026, CUROHOLDINGS Co., Ltd. has 5.15M shares outstanding.
| Shares Outstanding | 5.15M |
These figures are as of March 31, 2026. The price-to-sales ratio is 0.30, and the price-to-book ratio stands at 0.71.
| PS Ratio | 0.30 |
| PB Ratio | 0.71 |
| P/TBV Ratio | 0.72 |
| P/FCF Ratio | -4.35 |
| P/OCF Ratio | -4.94 |
As of March 31, 2026, CUROHOLDINGS Co., Ltd. trades at an EV/EBITDA multiple of 49.24 - the valuation measure that neutralizes differences in capital structure, tax rates, and depreciation policy, making it the standard yardstick for comparing companies across an industry. The EV/Sales ratio of 1.05 reflects the premium investors pay for the company's revenue stream, a useful check when earnings are depressed or negative. These enterprise value multiples are built on an enterprise value of 58.11B versus a market cap of 17.84B, with the gap driven by net debt and cash on the balance sheet.
| EV / Sales | 1.05 |
| EV / EBITDA | 49.24 |
As of March 31, 2026, CUROHOLDINGS Co., Ltd. maintains a current ratio of 0.85, meaning it holds 0.8x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 143.49, indicating elevated leverage, while an interest coverage ratio of 0.38 demonstrates limited ability to service its debt obligations.
| Current Ratio | 0.85 |
| Quick Ratio | 0.03 |
| Debt / Equity | 143.49 |
| Debt / EBITDA | 33.38 |
| Interest Coverage | 0.38 |
Over the twelve months ended March 31, 2026, CUROHOLDINGS Co., Ltd. posted a negative return on equity (ROE) of -35.88, meaning shareholder capital produced losses rather than profits. Return on assets (ROA) is negative at -9.01, reflecting losses generated across the asset base. The company generates approximately 1.22B in revenue per employee across its workforce of 45.50, a quick read on workforce productivity versus industry peers. Inventory turnover of 1.25 indicates how many times CUROHOLDINGS Co., Ltd. sells and replaces its inventory over a year, a key working capital efficiency ratio.
| Return on Equity (ROE) | -35.88 |
| Return on Assets (ROA) | -9.01 |
| Revenue Per Employee | 1.22B |
| Employee Count | 45.50 |
| Inventory Turnover | 1.25 |
Over the twelve months ended March 31, 2026, CUROHOLDINGS Co., Ltd. recorded 652.21M in income tax expense. The company reported a pretax loss of -7.69B and -8.15B in bottom-line net income, so the effective tax rate carries little signal until profitability returns.
| Income Tax | 652.21M |
As of the close on October 23, 2026, CUROHOLDINGS Co., Ltd.'s stock has declined approximately 67.61% over the past 52 weeks. The 50-day moving average sits at 2,584.00, while the 200-day moving average is 3,723.95.
| 52-Week Price Change | -67.61% |
| 50-Day Moving Average | 2,584.00 |
| 200-Day Moving Average | 3,723.95 |
Over the twelve months ended March 31, 2026, CUROHOLDINGS Co., Ltd. generated 55.31B in revenue and converted that into -8.15B in net income, yielding earnings per share of -1,736.32. EBITDA reached 1.18B, while operating income came in at 306.08M.
| Revenue | 55.31B |
| Gross Profit | 11.93B |
| Operating Income | 306.08M |
| Pretax Income | -7.69B |
| Net Income | -8.15B |
| EBITDA | 1.18B |
| EBIT | -165.48M |
| Earnings Per Share (EPS) | -1,736.32 |
As of March 31, 2026, CUROHOLDINGS Co., Ltd. holds 1.43B in cash and equivalents against 39.39B in total debt, resulting in a net debt position of 35.78B. Total book value stands at 25.15B, with working capital of -8.56B providing operational flexibility.
| Cash & Cash Equivalents | 1.43B |
| Total Debt | 39.39B |
| Net Debt | 35.78B |
| Equity (Book Value) | 25.15B |
| Book Value Per Share | 4,885.43 |
| Working Capital | -8.56B |
CUROHOLDINGS Co., Ltd. produced -3.37B in operating cash flow over the twelve months ended March 31, 2026. After subtracting -462.54M in capital expenditures, free cash flow totaled -3.83B - equivalent to -797.25 per share.
| Operating Cash Flow | -3.37B |
| Capital Expenditures | -462.54M |
| Free Cash Flow | -3.83B |
| FCF Per Share | -797.25 |
Over the twelve months ended March 31, 2026, CUROHOLDINGS Co., Ltd. posted a gross margin of 21.57, reflecting its pricing power and cost economics. The operating margin of 0.55 and net profit margin of -14.74 provide insight into operational efficiency.
| Gross Margin | 21.57 |
| Operating Margin | 0.55 |
| Pretax Margin | -13.91 |
| Profit Margin | -14.74 |
| EBITDA Margin | 2.13 |
These figures cover the twelve months ended March 31, 2026. Free cash flow yield is negative at -23.01: the business is consuming cash rather than generating it, so any dividend is not covered by free cash flow. Total shareholder yield reaches 26.08, combining dividends paid with share buybacks and debt reduction for a fuller picture of capital returned to CUROHOLDINGS Co., Ltd. shareholders.
| Shareholder Yield | 26.08 |
| FCF Yield | -23.01 |
CUROHOLDINGS Co., Ltd.'s most recent stock split took place on May 11, 2026 with a 5:1 split ratio.
| Last Split Date | 5/11/2026 |
| Split Ratio | 5:1 |
As of March 31, 2026, CUROHOLDINGS Co., Ltd. has an Altman Z-Score of -0.61, below the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.
| Altman Z-Score | -0.61 |
Already premium?